SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-20-053438
Filing Date
2020-04-29
Accepted
2020-04-29 16:42:09
Documents
10
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2017933d1_10ka.htm 10-K/A 704936
2 EXHIBIT 31.1 tm2017933d1_ex31-1.htm EX-31.1 4183
3 EXHIBIT 31.2 tm2017933d1_ex31-2.htm EX-31.2 4187
4 GRAPHIC image_001.jpg GRAPHIC 2191
5 GRAPHIC image_003.jpg GRAPHIC 2391
6 GRAPHIC image_004.jpg GRAPHIC 3084
7 GRAPHIC image_005.jpg GRAPHIC 3209
8 GRAPHIC image_006.jpg GRAPHIC 2496
9 GRAPHIC image_007.jpg GRAPHIC 2839
10 GRAPHIC image_008.jpg GRAPHIC 2458
  Complete submission text file 0001104659-20-053438.txt   740992
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26770 | Film No.: 20831008
SIC: 2836 Biological Products, (No Diagnostic Substances)